Cases 21 - 30 of 272
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2023cv01369
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00266
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Zydus Pharmaceuticals USA Inc.
as 1:2023mc00132
Petitioner:
Exelixis, Inc.
Respondent:
Zydus Pharmaceuticals USA Inc.
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND et al v. CELGENE CORPORATION et al
as 2:2022cv06694
Plaintiff:
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND and JACKSONVILLE POLICE OFFICERS AND FIRE FIGHTERS HEALTH INSURANCE TRUST
Defendant:
CELGENE CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, NATCO PHARMA LIMITED and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
ACADIA Pharmaceuticals Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv01386
Plaintiff:
ACADIA Pharmaceuticals Inc.
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv01291
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv05830
Defendant:
ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC and others
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SALIX PHARMACEUTICALS, INC. et al v. ZYDUS PHARMACEUTICALS (USA), INC. et al
as 2:2022cv05589
Plaintiff:
SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD. and BAUSCH HEALTH COMPANIES INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA), INC., ZYDUS WORLDWIDE DMCC and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2022cv04499
Plaintiff:
ASTELLAS PHARMA INC., ASTELLAS US LLC, ASTELLAS PHARMA US, INC. and others
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LTD
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
